Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-10

FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved Advagen Pharma Ltd's original application for buprenorphine hydrochloride, authorizing a generic product of buprenorphine for approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine Hydrochloride (Buprenorphine hydrochloride)

Snippet

ORIG AP for BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)